Back to Resource Hub White paper

Remote Ratings as an Adaptation to COVID-19

This white paper offers guidance on implementing remote ratings for studies operating during the COVID-19 crisis.

Signant's experts discuss methods to collect data that will identify where and how remote ratings are used. They also offer principles to maximize the quantity and quality of data even while operating under conditions of uncertainty.

Learn about the important considerations regarding legal and regulatory needs, operations, clinical requirements, logistics, safety, and engagement.

Similar posts

Looking for more insights? Explore related resources.

WHITE PAPER

Takeaways and Perspectives: FDA Draft Guidance on DCTs

READ THE PAPER
WHITE PAPER

Overcoming Data Quality Challenges During COVID-19

READ THE PAPER
GUIDE

Getting Started with eCOA

GET THE GUIDE

Get notified on new marketing insights

Here mention the benefits of subscribing